Eran Eden
Co-founder and CEO
Infectious Diseases
Memed
Australia
Biography
Dr. Eden has been the CEO of MeMed since its inception in 2009, leading it from an idea to a rapidly growing company. He has 13 years of combined business and academic experience leading the development of cutting-edge multidisciplinary technologies that synergize molecular biology and informatics. Dr. Eden co-founded several highly funded international consortia (e.g., Tailored-Treatment and Respiratory-ImmunoDx), the mission of which is to develop, clinically validate and commercialize novel technologies for diagnosing patients with infectious diseases and inflammatory disorders. He holds a B.Sc. in Computer Engineering, B.A. in Biology, and M.Sc. in Computer Science (all Cum Laude) from the Technion, Israel Institute of Technology, and a Ph.D. in Systems Biology from the Weizmann Institute of Science. Dr. Eden is co-author of 11 patents and 16 peer-reviewed publications and is the recipient of multiple awards including the prestigious GE and Science Prize for Promising Life Scientists.
Research Interest
Dr. Eden has been the CEO of MeMed since its inception in 2009, leading it from an idea to a rapidly growing company. He has 13 years of combined business and academic experience leading the development of cutting-edge multidisciplinary technologies that synergize molecular biology and informatics. Dr. Eden co-founded several highly funded international consortia (e.g., Tailored-Treatment and Respiratory-ImmunoDx), the mission of which is to develop, clinically validate and commercialize novel technologies for diagnosing patients with infectious diseases and inflammatory disorders. He holds a B.Sc. in Computer Engineering, B.A. in Biology, and M.Sc. in Computer Science (all Cum Laude) from the Technion, Israel Institute of Technology, and a Ph.D. in Systems Biology from the Weizmann Institute of Science. Dr. Eden is co-author of 11 patents and 16 peer-reviewed publications and is the recipient of multiple awards including the prestigious GE and Science Prize for Promising Life Scientists.